Unknown

Dataset Information

0

Mitochondrial oxidative stress as a novel therapeutic target to overcome intrinsic drug resistance in melanoma cell subpopulations.


ABSTRACT: Despite recent success in melanoma therapy, most patients with metastatic disease still undergo deadly progression. We have identified a novel mechanism of multidrug resistance allowing a small subpopulation of slow-cycling melanoma cells to survive based on elevated oxidative bioenergy metabolism. In this study, we asked whether such slow-cycling cells could be eliminated by co-treatment with the copper-chelator elesclomol. Elesclomol-copper complexes can cause oxidative stress by disruption of the mitochondrial respiration chain or by indirect non-mitochondrial induction of reactive oxygen species. We have found that elesclomol effectively kills the slow-cycling subpopulation and prevents the selective enrichment for slow-cycling cells, which usually results after monotreatment. We hypothesize that elesclomol could overcome the multidrug resistance of slow-cycling melanoma cells and prevent tumor repopulation in melanoma patients in future.

SUBMITTER: Cierlitza M 

PROVIDER: S-EPMC4335723 | biostudies-literature | 2015 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Mitochondrial oxidative stress as a novel therapeutic target to overcome intrinsic drug resistance in melanoma cell subpopulations.

Cierlitza Monika M   Chauvistré Heike H   Bogeski Ivan I   Zhang Xin X   Hauschild Axel A   Herlyn Meenhard M   Schadendorf Dirk D   Vogt Thomas T   Roesch Alexander A  

Experimental dermatology 20150201 2


Despite recent success in melanoma therapy, most patients with metastatic disease still undergo deadly progression. We have identified a novel mechanism of multidrug resistance allowing a small subpopulation of slow-cycling melanoma cells to survive based on elevated oxidative bioenergy metabolism. In this study, we asked whether such slow-cycling cells could be eliminated by co-treatment with the copper-chelator elesclomol. Elesclomol-copper complexes can cause oxidative stress by disruption of  ...[more]

Similar Datasets

| S-EPMC6397704 | biostudies-literature
| S-EPMC3422349 | biostudies-literature
| S-EPMC8038312 | biostudies-literature
| S-EPMC4855947 | biostudies-literature
| S-EPMC2769247 | biostudies-literature
| S-EPMC7516126 | biostudies-literature
| S-EPMC4046789 | biostudies-other
| S-EPMC7241280 | biostudies-literature
| S-EPMC6355443 | biostudies-literature
| S-EPMC11321625 | biostudies-literature